Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel.

Experimental and molecular pathology - 1 Jun 2015

Cimino Patrick J, Bredemeyer Andy, Abel Haley J, Duncavage Eric J

Abstract excerpt

With the advent of large-scale genomic analysis, the genetic landscape of glioblastoma (GBM) has become more clear, including characteristic genetic alterations in EGFR. In routine clinical practice, genetic alterations in GBMs are identified using several disparate techniques that consume already limited amounts of tissue and add to overall testing costs. In this study, we sought to determine if the full...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Glioblastoma

Share to High-Throughput Nucleotide Sequencing

Share to Polymorphism, Single Nucleotide

Share to Sequence Analysis, DNA

Source

Open in PubMed Open full text

Identifiers

PMID: 25910966
DOI: 10.1016/j.yexmp.2015.04.006
PMCID: PMC4539240

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel.PMID 25910966Read ↗

Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.Semantic proximity Read ↗

Comprehensive Molecular Genetic Analysis in Glioma Patients by Next Generation SequencingSemantic proximity Read ↗

Molecular pathologic diagnosis of epidermal growth factor receptor.Semantic proximity Read ↗

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.Semantic proximity Read ↗

Whole Genome Sequencing-Based Discovery of Structural Variants in Glioblastoma.Semantic proximity Read ↗

EGFR heterogeneity and implications for therapeutic intervention in glioblastoma.Semantic proximity Read ↗

Comprehensive somatic mutational analysis in glioblastoma: Implications for precision medicine approaches.Semantic proximity Read ↗

Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing.Semantic proximity Read ↗

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors.Semantic proximity Read ↗

Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in GliomasSemantic proximity Read ↗

Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene PanelSemantic proximity Read ↗

Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear PreparationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.